Impact Biomedical Stock

Impact Biomedical P/B

The P/B (Price-to-Book Ratio) of Impact Biomedical (IBO) as of Aug 12, 2026 is 11.37. In the previous year, P/B (Price-to-Book Ratio) was 1.92 — a change of 492.20% (higher).

P/B

11.37

YoY

492.20%

Last updated:

P/B (Price-to-Book Ratio) of Impact Biomedical is 2026 11.37 . P/B (Price-to-Book Ratio) of Impact Biomedical was 2025 1.92 . It decreases by 492.20% higher compared to the previous year.
Access this data via the Eulerpool API

Impact Biomedical Stock analysis

What does Impact Biomedical do? Impact Biomedical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Impact Biomedical stock

P/B (Price-to-Book Ratio) of Impact Biomedical is 11.37 in 2026.

P/B (Price-to-Book Ratio) of Impact Biomedical changed from 1.92 to 11.37, representing a 492.20% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of P/B (Price-to-Book Ratio) Impact Biomedical since 2006 – with annual values, charts, and detailed analysis.

The Price-to-Book ratio compares a company's market price to its book value. A low P/B may indicate an undervalued stock, while a high P/B could suggest overvaluation or strong growth expectations.

P/B = Stock Price / Book Value per Share

To evaluate P/B (Price-to-Book Ratio)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for P/B (Price-to-Book Ratio).

A 'good' varies by industry and company stage. On Eulerpool, you can compare P/B (Price-to-Book Ratio)'s Impact Biomedical with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Impact Biomedical

All Key Metrics — Impact Biomedical